ER–Golgi network—A future target for anti-cancer therapy

Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Broker, 2005, Cell death independent of caspases: a review, Clin Cancer Res, 11, 3155, 10.1158/1078-0432.CCR-04-2223 Crighton, 2004, Splicing DNA-damage responses to tumour cell death, Biochim Biophys Acta, 1705, 3 Meng, 2006, Apoptosis in the treatment of cancer: a promise kept?, Curr Opin Cell Biol, 18, 668, 10.1016/j.ceb.2006.10.008 Lowe, 1993, p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents, Cell, 74, 957, 10.1016/0092-8674(93)90719-7 Kaufmann, 2000, Apoptosis in cancer: cause and cure, Bioessays, 22, 1007, 10.1002/1521-1878(200011)22:11<1007::AID-BIES7>3.0.CO;2-4 Ghobrial, 2005, Targeting apoptosis pathways in cancer therapy, CA Cancer J Clin, 55, 178, 10.3322/canjclin.55.3.178 Leist, 2001, Four deaths and a funeral: from caspases to alternative mechanisms, Nat Rev Mol Cell Biol, 2, 589, 10.1038/35085008 Jaattela, 2002, Programmed cell death: many ways for cells to die decently, Ann Med, 34, 480, 10.1080/078538902321012423 Lockshin, 2001, Programmed cell death and apoptosis: origins of the theory, Nat Rev Mol Cell Biol, 2, 545, 10.1038/35080097 Okada, 2004, Pathways of apoptotic and non-apoptotic death in tumour cells, Nat Rev Cancer, 4, 592, 10.1038/nrc1412 Edinger, 2004, Death by design: apoptosis, necrosis and autophagy, Curr Opin Cell Biol, 16, 663, 10.1016/j.ceb.2004.09.011 Abraham, 2004, Death without caspases, caspases without death, Trends Cell Biol, 14, 184, 10.1016/j.tcb.2004.03.002 Hail, 2006, Apoptosis effector mechanisms: a requiem performed in different keys, Apoptosis, 11, 889, 10.1007/s10495-006-6712-8 Levine, 2005, Autophagy in cell death: an innocent convict?, J Clin Invest, 115, 2679, 10.1172/JCI26390 Kroemer, 2005, Lysosomes and autophagy in cell death control, Nat Rev Cancer, 5, 886, 10.1038/nrc1738 Kim, 2005, Recent advances in understanding the cell death pathways activated by anticancer therapy, Cancer, 103, 1551, 10.1002/cncr.20947 Kim, 2006, Role of mitochondria as the gardens of cell death, Cancer Chemother Pharmacol, 57, 545, 10.1007/s00280-005-0111-7 Ferri, 2001, Organelle-specific initiation of cell death pathways, Nat Cell Biol, 3, E255, 10.1038/ncb1101-e255 Maag, 2003, Death from within: apoptosis and the secretory pathway, Curr Opin Cell Biol, 15, 456, 10.1016/S0955-0674(03)00075-9 Momoi, 2004, Caspases involved in ER stress-mediated cell death, J Chem Neuroanat, 28, 101, 10.1016/j.jchemneu.2004.05.008 Hicks, 2005, Golgi structure in stress sensing and apoptosis, Biochim Biophys Acta, 1744, 406, 10.1016/j.bbamcr.2005.03.002 Szegezdi, 2006, Mediators of endoplasmic reticulum stress-induced apoptosis, EMBO Rep, 7, 880, 10.1038/sj.embor.7400779 Orrenius, 2003, Regulation of cell death: the calcium–apoptosis link, Nat Rev Mol Cell Biol, 4, 552, 10.1038/nrm1150 Scorrano, 2003, Mechanisms of cytochrome c release by proapoptotic BCL-2 family members, Biochem Biophys Res Commun, 304, 437, 10.1016/S0006-291X(03)00615-6 Scorrano, 2003, BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis, Science, 300, 135, 10.1126/science.1081208 Chipuk, 2003, Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription, Cancer Cell, 4, 371, 10.1016/S1535-6108(03)00272-1 Chipuk, 2003, p53's believe it or not: lessons on transcription-independent death, J Clin Immunol, 23, 355, 10.1023/A:1025365432325 Chipuk, 2006, Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario, Cell Death Differ, 13, 1396, 10.1038/sj.cdd.4401963 Skommer, 2007, Larger than life: mitochondria and the Bcl-2 family, Leuk Res, 31, 277, 10.1016/j.leukres.2006.06.027 Machamer, 2003, Golgi disassembly in apoptosis: cause or effect?, Trends Cell Biol, 13, 279, 10.1016/S0962-8924(03)00101-6 Rutkowski, 2004, A trip to the ER: coping with stress, Trends Cell Biol, 14, 20, 10.1016/j.tcb.2003.11.001 Walter, 2005, Mitochondria and endoplasmic reticulum: the lethal interorganelle cross-talk, J Bioenerg Biomembr, 37, 191, 10.1007/s10863-005-6600-x Bertolotti, 2000, Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response, Nat Cell Biol, 2, 326, 10.1038/35014014 Katayama, 1999, Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response, Nat Cell Biol, 1, 479, 10.1038/70265 Patil, 2001, Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals, Curr Opin Cell Biol, 13, 349, 10.1016/S0955-0674(00)00219-2 McCullough, 2001, Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state, Mol Cell Biol, 21, 1249, 10.1128/MCB.21.4.1249-1259.2001 Shiraishi, 2005, Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells, Cancer Res, 65, 6364, 10.1158/0008-5472.CAN-05-0312 Li, 2006, Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53, J Biol Chem, 281, 7260, 10.1074/jbc.M509868200 Yoneda, 2001, Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress, J Biol Chem, 276, 13935, 10.1074/jbc.M010677200 Urano, 2000, IRE1 and efferent signaling from the endoplasmic reticulum, J Cell Sci, 113, 3697, 10.1242/jcs.113.21.3697 Bassik, 2004, Phosphorylation of BCL-2 regulates ER Ca2+ homeostasis and apoptosis, EMBO J, 23, 1207, 10.1038/sj.emboj.7600104 Lei, 2003, JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis, Proc Natl Acad Sci USA, 100, 2432, 10.1073/pnas.0438011100 van de Craen, 1997, Characterization of seven murine caspase family members, FEBS Lett, 403, 61, 10.1016/S0014-5793(97)00026-4 Nakagawa, 2000, Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta, Nature, 403, 98, 10.1038/47513 Nakagawa, 2000, Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis, J Cell Biol, 150, 887, 10.1083/jcb.150.4.887 Liu, 2005, Endoplasmic reticulum stress-associated caspase 12 mediates cisplatin-induced LLC-PK1 cell apoptosis, J Am Soc Nephrol, 16, 1985, 10.1681/ASN.2004090768 Morishima, 2002, An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12, J Biol Chem, 277, 34287, 10.1074/jbc.M204973200 Fischer, 2002, Human caspase 12 has acquired deleterious mutations, Biochem Biophys Res Commun, 293, 722, 10.1016/S0006-291X(02)00289-9 Hitomi, 2004, Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death, J Cell Biol, 165, 347, 10.1083/jcb.200310015 Breckenridge, 2002, The procaspase-8 isoform, procaspase-8L, recruited to the BAP31 complex at the endoplasmic reticulum, Proc Natl Acad Sci USA, 99, 4331, 10.1073/pnas.072088099 Thomenius, 2003, Bcl-2 on the endoplasmic reticulum: protecting the mitochondria from a distance, J Cell Sci, 116, 4493, 10.1242/jcs.00829 Chen, 2004, Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate, J Cell Biol, 166, 193, 10.1083/jcb.200309146 Mannella, 1998, Electron microscopic tomography of rat-liver mitochondria and their interaction with the endoplasmic reticulum, Biofactors, 8, 225, 10.1002/biof.5520080309 Rizzuto, 1998, Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses, Science, 280, 1763, 10.1126/science.280.5370.1763 Boehning, 2003, Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis, Nat Cell Biol, 5, 1051, 10.1038/ncb1063 Guicciardi, 2003, Calpains can do it alone: implications for cancer therapy, Cancer Biol Ther, 2, 153, 10.4161/cbt.2.2.349 Sesso, 1999, Structural elements common to mitosis and apoptosis, Tissue Cell, 31, 357, 10.1054/tice.1999.0042 Ruan, 2004, Polo-like kinase 3 is Golgi localized and involved in regulation of Golgi fragmentation during the cell cycle, Exp Cell Res, 294, 51, 10.1016/j.yexcr.2003.10.022 Jiang, 2006, Polo box domain of Plk3 functions as a centrosome localization signal, overexpression of which causes mitotic arrest, cytokinesis defects, and apoptosis, J Biol Chem, 281, 10577, 10.1074/jbc.M513156200 Wang, 2007, Stress-induced c-Jun activation mediated by Polo-like kinase 3 in corneal epithelial cells, J Biol Chem, 282, 32121, 10.1074/jbc.M702791200 Wang, 2002, Cell cycle arrest and apoptosis induced by human Polo-like kinase 3 is mediated through perturbation of microtubule integrity, Mol Cell Biol, 22, 3450, 10.1128/MCB.22.10.3450-3459.2002 Li, 2005, Function of polo-like kinase 3 in NF-kappaB-mediated proapoptotic response, J Biol Chem, 280, 16843, 10.1074/jbc.M410119200 Syed, 2006, Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies, Blood, 107, 250, 10.1182/blood-2005-03-1194 Mancini, 2000, Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis, J Cell Biol, 149, 603, 10.1083/jcb.149.3.603 Chiu, 2002, A caspase cleavage fragment of p115 induces fragmentation of the Golgi apparatus and apoptosis, J Cell Biol, 159, 637, 10.1083/jcb.200208013 Lane, 2002, Caspase-mediated cleavage of the stacking protein GRASP65 is required for Golgi fragmentation during apoptosis, J Cell Biol, 156, 495, 10.1083/jcb.200110007 Tinel, 2004, a protein complex implicated in activation of caspase-2 in response to genotoxic stress, Science, 304, 843, 10.1126/science.1095432 Maag, 2005, Caspase-resistant Golgin-160 disrupts apoptosis induced by secretory pathway stress and ligation of death receptors, Mol Biol Cell, 16, 3019, 10.1091/mbc.E04-11-0971 Hauser, 1998, A giant ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors, J Cell Biol, 141, 1415, 10.1083/jcb.141.6.1415 Malisan, 2002, GD3 ganglioside and apoptosis, Biochim Biophys Acta, 1585, 179, 10.1016/S1388-1981(02)00339-6 Rippo, 2000, GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion, FASEB J, 14, 2047, 10.1096/fj.99-1028com Tomassini, 2004, Calnexin suppresses GD3 synthase-induced apoptosis, FASEB J, 18, 1553, 10.1096/fj.04-1675fje Cristea, 2004, Membrane lipids and cell death: an overview, Chem Phys Lipids, 129, 133, 10.1016/j.chemphyslip.2004.02.002 Bennett, 1998, Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis, Science, 282, 290, 10.1126/science.282.5387.290 Arvan, 2002, Secretory pathway quality control operating in Golgi, plasmalemmal, and endosomal systems, Traffic, 3, 771, 10.1034/j.1600-0854.2002.31102.x Linder, 2005, Lysosomes and endoplasmic reticulum: targets for improved, selective anticancer therapy, Drug Resist Updat, 8, 199, 10.1016/j.drup.2005.06.004 Carew, 2006, Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL, Blood, 107, 222, 10.1182/blood-2005-05-1923 Jaattela, 2004, Multiple cell death pathways as regulators of tumour initiation and progression, Oncogene, 23, 2746, 10.1038/sj.onc.1207513 Carew, 2004, Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine, Leukemia, 18, 1934, 10.1038/sj.leu.2403545 Donaldson, 1992, ADP-ribosylation factor, a small GTP-binding protein, is required for binding of the coatomer protein beta-COP to Golgi membranes, Proc Natl Acad Sci USA, 89, 6408, 10.1073/pnas.89.14.6408 Cheung, 2006, Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs, Exp Cell Res, 312, 2347, 10.1016/j.yexcr.2006.03.027 Shao, 1996, Brefeldin A is a potent inducer of apoptosis in human cancer cells independently of p53, Exp Cell Res, 227, 190, 10.1006/excr.1996.0266 Wallen, 2000, Brefeldin A induces p53-independent apoptosis in primary cultures of human prostatic cancer cells, Urol, 164, 836, 10.1016/S0022-5347(05)67323-5 Salles, 2004, Brefeldin-A induces apoptosis in human adenoid cystic carcinoma cultured cells, Oral Oncol, 40, 585, 10.1016/j.oraloncology.2003.12.007 Boya, 2002, Endoplasmic reticulum stress-induced cell death requires mitochondrial membrane permeabilization, Cell Death Differ, 9, 465, 10.1038/sj.cdd.4401006 Wlodkowic, 2007, Brefeldin A triggers apoptosis associated with mitochondrial breach and enhances HA14-1- and anti-Fas-mediated cell killing in follicular lymphoma cells, Leukemia Res, 31, 1687, 10.1016/j.leukres.2007.03.008 Sausville, 1996, antiproliferative effect in vitro and antitumor activity in vivo of brefeldin A, Cancer J Sci Am, 2, 52 Phillips, 1993, Analysis of Brefeldin A in plasma by gas chromatography with electron capture, Anal Biochem, 211, 16, 10.1006/abio.1993.1225 Phillips, 1998, Analysis of brefeldin A and the prodrug breflate in plasma by gas chromatography with mass selective detection, J Pharm Biomed Anal, 16, 1301, 10.1016/S0731-7085(97)00142-8 Brown, 2005, The role of apoptosis in cancer development and treatment response, Nat Rev Cancer, 5, 231, 10.1038/nrc1560 Green, 2005, Pharmacological manipulation of cell death: clinical applications in sight?, J Clin Invest, 115, 2610, 10.1172/JCI26321 Chapman, 1999, Mechanism of Brefeldin A-induced growth inhibition and cell death in human prostatic carcinoma cells, Mol Urol, 3, 11 Tinhoffer, 2002, Stressful death of T-ALL tumor cells after treatment with the anti-tumor agent Tetrocarcin-A, FASEB J, 16, 1295, 10.1096/fj.02-0020fje Anether, 2003, Tetrocarcin-A-induced ER stress mediates apoptosis in B-CLL cells via a Bcl-2-independent pathway, Blood, 101, 4561, 10.1182/blood-2002-08-2501 Denmeade, 2005, The SERCA pump as a therapeutic target: making a “smart bomb” for prostate cancer, Cancer Biol & Ther, 4, 14, 10.4161/cbt.4.1.1505 Nawrocki, 2005, Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis, Cancer Res, 65, 11658, 10.1158/0008-5472.CAN-05-2370 Hoeller, 2009, Targeting the ubiquitin system in cancer therapy, Nature, 458, 438, 10.1038/nature07960 Bennett, 2008, Development of proteasome inhibitors in oncology and autoimmune diseases, Curr Opin Drug Discov Dev, 11, 616 Burger, 2004, The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications, Eur J Cancer, 40, 2217, 10.1016/j.ejca.2004.07.006 Hill, 2009, Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanoma, Clin Cancer Res, 15, 1192, 10.1158/1078-0432.CCR-08-2150 Wang, 2009, ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells, Proc Natl Acad Sci USA, 106, 2200, 10.1073/pnas.0807611106 Boelens, 2007, The endoplasmic reticulum: a target for new anticancer drugs, In Vivo, 21, 215